Homology Medicines Inc.

NASDAQ: FIXX · Real-Time Price · USD
0.93
0.00 (0.26%)
At close: Mar 25, 2024, 8:00 PM

Homology Medicines Revenue

Homology Medicines reported an annual revenue of $1.16M, reflecting a -63.97% growth. For the quarter ending March 31, 2024, Homology Medicines generated $0 in revenue.
Revenue (ttm)
$1.16M
Revenue Growth
-63.97%
Price / Sales Ratio
3.04
Revenue / Employee
$165.14K
Employees
7
Market Cap
3.02M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.